Arkolith/Insider Trading/AXSM/Form 4

Jacobson Mark L.

Chief Operating OfficerAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed Feb 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.7M
Net Open-Market Flow
-$5.7M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 26, 2026Option exercise(M)35K$2.85$101K35K
Feb 26, 2026Sell(S)35K$161.88$5.7M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 26, 2026Option exercise(M)35K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-083586) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML